Latent inhibition: The nucleus accumbens connection revisited

Behavioural Brain Research

Volumn 88, Issue 1, 1997, Pages 27-34

  Gray, J A ^a   Moran, P M ^a   Grigoryan, G ^a   Peters, S L ^a   Young, A M J ^a   Joseph, M H ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Amphetamine; Dopamine; In vivo microdialysis; Latent inhibition; Nucleus accumbens; Schizophrenia

Indexed keywords

AMPHETAMINE; HALOPERIDOL;

CONDITIONING; CONFERENCE PAPER; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; DOPAMINERGIC TRANSMISSION; EXPERIMENTAL MODEL; LATENT INHIBITION; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; SCHIZOPHRENIA;

ANIMALS; CONDITIONING, OPERANT; HUMANS; NUCLEUS ACCUMBENS; REINFORCEMENT (PSYCHOLOGY); STARTLE REACTION;

EID: 0030772245     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-4328(97)02313-9     Document Type: Conference Paper

References (34)

1. Brazell, M.P., Mitchell, S.N., Joseph, M.H. and Gray, J.A., Acute administration of nicotine increases the in vivo extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid and ascorbic acid preferentially in the nucleus accumbens of the rat: comparison with caudate-putamen, Neuropharmacology, 29 (1990) 1177-1185.
2. Cador, M., Bijou, Y. and Stinus, L., Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioural sensitisation to amphetamine, Neuroscience, 65 (1995) 385-395.
3. Dunn, L.A., The latent inhibition model of schizophrenic attention disorder and of antipsychotic drug action: comment on Dunn, Atwater and Kilts (Psychopharmacology, 112 (1993) 315-323), Psychopharmacology, 116 (1994) 381.
4. Dunn, L.A., Atwater, G.E. and Kilts, C.D., Effects of antipsychotic drugs on latent inhibition: sensitivity and specificity of an animal behavioural model of clinical drug action, Psychopharmacology, 112 (1993) 315-325.
5. Feldon J. and Weiner I., An animal model of attention deficit. In: A.A. Boulton, G.B. Baker and M.T. Martin-Iverson (Eds.), Neuromethods. Animal Models in Psychiatry, Humana Press, Clifton, NJ, 1991, pp. 313-361.
6. Gray, J.A., Feldon, J., Rawlins, J.N.P., Hemsley, D.R., Dawling, S. and Smith, A.D., The neuropsychology of schizophrenia, Behav. Brain Sci., 14 (1991) 1-20.
7. Gray, J.A., Hemsley, D.R., Feldon, J., Gray, N.S. and Rawlins, J.N.P., Schiz bits: misses, mysteries and hits, Behav. Brain Sci., 14 (1991) 56-84.
8. Gray, J.A., Joseph, M.H., Hemsley, D.R., Young, A.M.J., Warburton, E.C., Boulenguez, P., Grigoryan, G.A., Peters, S.L., Rawlins, J.N.P., Taib, C.-T., Yee, B.K., Cassaday, H., Weiner, I., Gal, G., Gusak, O., Joel, D., Shadach, E., Shalev, U., Tarrasch, R. and Feldon, J., The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia, Behav. Brain Res., 71 (1995) 19-31.
9. Gray, N.S., Pickering, A.D., Hemsley, D.R., Dawling, S. and Gray, J.A., Abolition of latent inhibition by a single dose of d-amphetamine in man, Psychopharmacology, 107 (1992) 425-430.
10. Imperato, A., Mulas, A. and Di Chiara, G., Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats, Eur. J. Pharmacol., 132 (1986) 337-338.
11. Joseph, M.H., Peters, S.L. and Gray, J.A., Nicotine blocks latent inhibition in rats: evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure, Psychopharmacology, 110 (1993) 187-192.
12. Joseph, M.H., Naylor, C.G.G. and Peters, S.L. Amphetamine disruption of latent inhibition is prevented by haloperidol given only at conditioning, but not at pre-exposure. J. Psychopharmacol., 118(Suppl.) (1993), A8.
13. Kalivas, P.W. and Stewart, J., Dopamine transmission in the initiation and expression of drug- and stress-induced sensitisation of motor activity, Brain Res. Rev., 16 (1991) 223-244.
14. Kelly, P.H., Seviour, P.W. and Iversen, S.D., Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum, Brain Res., 94 (1975) 507-522.
15. Killcross, S. and Dickinson, A. Contextual control of latent inhibition by the reinforcer, Q. J. Exp. Psychol., 49B (1996) 45-59.
16. Killcross, A.S., Dickinson, A. and Robbins, T.W., Amphetamine-induced disruptions of latent inhibition are reinforcer mediated: implications for animal models of schizophrenic attentional dysfunction, Psychopharmacology, 115 (1994) 185-195.
17. Killcross, A.S., Dickinson, A. and Robbins, T.W., Effects of the neuroleptic α-flupenthixol on latent inhibition in aversively-and appetitively-motivated paradigms: evidence for dopamine-reinforcer reactions, Psychopharmacology, 115 (1994) 196-205.
18. Killcross, A.S. and Robbins, T.W., Differential effects of intra-accumbens and systemic amphetamine on latent inhibition using an on-baseline, within-subject conditioned suppression paradigm, Psychopharmacology, 110 (1993) 479-489.
19. Lubow, R.E., Latent Inhibition and Conditioned Attention Theory, Cambridge University Press, Cambridge, 1989.
20. Lubow, R.E. and Moore, A.U., Latent inhibition: the effect of non-reinforced pre-exposure to the conditioned stimulus, J. Comp. Physiol. Psychol., 52 (1959) 415-419.
21. McAllister, K.H., A single administration of d-amphetamine prior to stimulus pre-exposure and conditioning attenuates latent inhibition, Psychopharmacology, 130 (1997) 79-84.
22. Peters, S.L. and Joseph, M.H., Haloperidol potentiation of latent inhibition in rats: evidence for a critical role at conditioning rather than pre-exposure, Behav. Pharmacol., 4 (1993) 183-186.
23. Rochford, J., Sen, A.P. and Quirion, R. Effect of nicotine and nicotinic receptor agonists on latent inhibition in the rat, J. Pharmacol. Exp. Ther., 277 (1996) 1267-1275.
24. Schmajuk, N.A., Lam, Y-W. and Gray, J.A., Latent inhibition: a neural network approach, J. Exp. Psychol. Anim. Behav. Proc., 22 (1996) 321-349.
25. Solomon, P.R. and Staton, D.M., Differential effects of microinjections of d-amphetamine into the nucleus accumbens or the caudate-putamen on the rat's ability to ignore an irrelevant stimulus, Biol. Psychiat., 17 (1982) 742-756.
26. Tai, C.-T., Cassaday, H.J., Feldon, J. and Rawlins, J.N.P., Both electrolytic and excitotoxic lesions of nucleus accumbens disrupt latent inhibition in rats, Neurobiol. Learn. Mem., 64 (1995) 36-48.
27. Thornton, J.C., Dawe, S., Lee, C., Frangou, S., Gray, N.S., Russell, M.A.H. and Gray, J.A., Effects of nicotine and amphetamine on latent inhibition in human beings, Psychopharmacology, 127 (1996) 164-173.
28. Vezina, P., Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo dialysis study in the rat, Brain Res., 605 (1993) 332-337.
29. Warburton, E.C., Joseph, M.H., Feldon, J., Weiner, I. and Gray, J.A., Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron, Psychopharmacology, 114 (1994) 657-664.
30. Warburton, E.C., Mitchell, S.N. and Joseph, M.H., Calcium dependent dopamine release in rat nucleus accumbens following amphetamine challenge: implications for the disruption of latent inhibition, Behav. Pharmacol., 1 (1996) 119-129.
31. Weiner, I., Neural substrates of latent inhibition: the switching model, Psychol. Bull., 108 (1990) 442-461.
32. Weiner, I., Izraeli-Telerant, A. and Feldon, J., Latent inhibition is not affected by acute or chronic administration of 6 mg/kg d-amphetamine, Psychopharmacology, 91 (1987) 345-351.
33. Weiner, I., Lubow, R.E. and Feldon, J., Disruption of latent inhibition by acute administration of low doses of amphetamine, Pharmacol. Biochem. Behav., 30 (1988) 871-878.
34. Young, A.M.J., Joseph, M.H. and Gray, J.A., Latent inhibition of conditioned dopamine release in nucleus accumbens, Neuroscience, 54 (1993) 5-9.